AP
Therapeutic Areas
Verseon Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anticoagulation | Preventing heart attacks & strokes with lower bleeding risk | Clinical |
| Diabetic Vision Loss | Preventing & treating diabetic retinopathy/macular edema without eye injections | IND-Prep |
| Multidrug-Resistant Cancers | Chemo agents for multidrug-resistant cancers | Preclinical |
| Solid-Tumor Metastasis | Preventing aggressive solid-tumor cancer metastasis | Optimization |
| CD73-Positive Cancers | Restoring immune response to CD73 positive cancers | Preclinical |